MedPath
NMPA Approval

Sulodexide Injection

国药准字HJ20181174

March 19, 2021

H20181174

Drug Information

舒洛地特注射液

伟素

伟素

注射剂

2ml:600LSU

化学药品

March 19, 2021

March 18, 2026

Company Information

Applicant Company

ALFASIGMA SPA

VIA RAGAZZI DEL’ 99, 5- 40133 BOLOGNA

Manufacturing Company

ALFASIGMA SPA

VIA ENRICO FERMI, 1-65020 ALANNO(PE) ITALY

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

舒洛地特注射液 - NMPA 批准文号 | MedPath